General

Apply Now for the EURORDIS 2025 Open Academy Trainings

Posted on
Eurordis Call Launch 3

Applications are now open for the 2025 edition of the Open Academy Schools, offering intensive, face-to-face training in Barcelona from 2-5 June 2025. This year, the Schools on Medicines Research & Development and Scientific Innovation & Translational Research will run in parallel, featuring expert-led sessions on patient engagement, leadership, and a research facility visit. A new online programme on data, ethics, and AI in rare disease research will also be launched, running from January to June 2025.

The Open Academy Schools enter a new era under the European Rare Diseases Research Alliance (ERDERA) partnership. The Schools [...]

Read

 
 
 

European Partnership Opens a New Era in Rare Disease Research

Posted on
ERDERA visual

The European Rare Diseases Research Alliance (ERDERA) kicks off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

To address these important issues, the European Rare Diseases Research Alliance (ERDERA) has been set up to build on the advancements made by former EU funded projects such as SOLVE-RD, ERICA and the European Joint Programme for Rare Diseases (EJP RD), the previous partnership which has run for the past 5 years.

To leave no one behind, over 170 organizations championed by the European [...]

Read

 
 
 

PLEASE CONTRIBUTE: Cross-Border Access to Paediatric Clinical Trials Survey

Posted on
xr:d:DAFfc0fthLE:12,j:5804410855870229120,t:23071719

The Cross-Border Access to Paediatric Clinical Trials Working Group (WG) created by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is collecting data. The aim of this WG is to facilitate the inclusion of children and young people in clinical trials across Europe avoiding any language barriers. Recently we have identified that some patients could not take part in a clinical trial because they do not speak the official language of the country where the trial is performed or English.

Enpr-EMA is currently collecting data from Clinical Research Units and, also from parents of children living [...]

Read

 
 
 
 
 
 

ERN input to ACT-EU priorities- Survey!

Posted on
ACT EU logo
ACT-EU* – Accelerating Clinical Trials in the EU

Please contribute to ACT-EU survey

Target group: Academic Stakeholders

The aim of the survey is to identify needs and priorities of academic stakeholders involved in clinical trials, integrating them into the work of ACT EU. It seeks to address challenges in conducting clinical trials in the EU faced by ERNs and academics, highlight topics needing further clarification or discussion, and propose solutions for improving and accelerating clinical trials. Academic stakeholders are encouraged to contribute ideas for improvement across various aspects of clinical trial governance and implementation, clinical trial methodologies [...]

Read

 
 
 
 
 
 

Presentations ERICA & EJP RD Joint Conference available!

Posted on
Groepsfoto-Endocrinologie- november 2023 -4-k

The European Rare Disease Research Coordination and Support Action- ERICA and European Joint Programme of Rare Diseases (EJP RD)

Joint Conference took place 21st November 2023 in Amsterdam University Medical Centre.

Main topics:

Examples of Synergies between both projects (ERICA & EJP RD) Collaboration of ERNs and non-ERNs researchers Preparing the path to the European Rare Diseases Research Alliance (ERDERA)

View the full programme (, 172 KB).

Overview of all Presentations ERICA & EJP RD Joint Conference.

Read